Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu injection for septic shock (microcirculation and endothelial function)
ChiCTR2200060107Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Aug 2019
- Countries
- 1
01
Overview
Phase 4, randomised trial of shenfu injection in septic shock (2 arms), sponsored by Renji Hospital. Primary endpoint: 28-day mortality. Started Aug 2019; status: completed.
02
Drugs
shenfu injection
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2200060107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060107.